biospace med Expands European Market Penetration with 'EOS', Which Cuts Radiation up to 90% vs. Conventional X-Rays

CAMBRIDGE, Mass. & PARIS--(BUSINESS WIRE)--Biospace med announced today that it continues to penetrate the European market with its CE Marked ‘EOS’ x-ray imager—the world’s first ultra-low-dose x-ray technology—recently adding two new regions of coverage in France: West (Brest University Hospital) and North (Lille University Hospital). These two recent installations are expanding national coverage with EOS in France as the Company already has systems operating in Paris, Lyon, Marseille, Bordeaux, and Nice.

Back to news